WELL Freedom Broker upgrades to Buy with $255 price target, citing diversified healthcare portfolio strength and Canadian expansion momentum.
Key data as of 5 Nov 2026
WELL Freedom Broker upgrades to Buy with $255 price target, citing diversified healthcare portfolio strength and Canadian expansion momentum.
Welltower enters its October 26 Q3 earnings report with short sellers holding an unusually small and stable position, while analyst conviction keeps building toward the top of the REIT universe. Short interest is…
WELL heads into its July 27 earnings release having gained nearly 20% over the past month, with options positioning flipping sharply bullish and analysts racing to lift targets. The clearest signal this week is in the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for WELL — free to start on ORTEX.
Sign up for free →Open WELL on ORTEX